Call for Abstracts
Abstract Submission Period
July 28(Tue) - September 10(Thu), 2026, 17:00
We recommend submitting your application with sufficient time to spare, as heavy traffic is expected just before the deadline, which may cause network congestion and interfere with presentation registration.
While it is possible to modify the registered abstract content online until the deadline, please note that modifications may not be possible due to congestion just before the deadline.
The email address you register will be used for communications regarding the 57th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery.
Please note that changes to co-authors and other details cannot be accepted after the registration deadline, so please be sure to complete any modifications during the presentation registration period.
While it is possible to modify the registered abstract content online until the deadline, please note that modifications may not be possible due to congestion just before the deadline.
The email address you register will be used for communications regarding the 57th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery.
Please note that changes to co-authors and other details cannot be accepted after the registration deadline, so please be sure to complete any modifications during the presentation registration period.
Eligibility Requirements
- Presentations are limited to unpublished original topics only.
- For inquiries regarding membership, please contact the Japanese Association for Thoracic Surgery office.
Membership Inquiry Contact
Japanese Society for Cardiovascular Surgery Room 202, 2nd Floor, Hirahara Building, 3-9-11 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
TEL：+81-3-5842-2301 FAX： +81-3-5842-2302
Email：jimu@jscvs.org
URL：https://jscvs.or.jp/
Presentation Format (Presentation Categories)
Main Theme Session
The author who selected “Main Theme Session” can choose whether to apply for “General Session (Oral/Poster/Video)” if not accepted as Main Theme Session.
■Valve and Arrhythmia
| Session Theme | ||
|---|---|---|
| 1 |
Conquering the Mitral Isthmus: The Pursuit of Complete Conduction Block and Rescue Strategies
This session will discuss surgical strategies for achieving reliable mitral annular line block during the Maze procedure, as well as intraoperative verification of block and postoperative rescue options, including hybrid interventions for recurrent conduction.
|
Symposium |
| 2 |
Management Strategies for Dialysis Patients with Aortic Stenosis in the TAVI Era: Has a Paradigm Shift in Valve Selection Occurred? ~ Mechanical Valve or Bioprosthetic Valve or Primary TAVI ~
In this session, we will examine current and future treatment strategies for patients on dialysis, addressing whether transcatheter aortic valve implantation (TAVI) can be considered the optimal therapeutic option, or whether surgical aortic valve replacement using mechanical or bioprosthetic valves offers superior outcomes.
|
Panel Discussion |
| 3 |
Open Surgery or M-TEER for Elderly Patients with Degenerative Mitral Regurgitation
This session will feature outcome data from high-volume centers comparing surgical mitral valve repair/replacement and mitral transcatheter edge-to-edge repair (M-TEER). Through these comparisons, we aim to discuss the optimal therapeutic approach for different patient populations and explore future directions in the management of mitral valve disease.
|
Panel Discussion |
| 4 |
Mitral Annuloplasty Techniques, Ring Selection, and Fixation Methods; Techniques for MAD
This session will bring together experts in mitral valve repair to discuss the conceptual frameworks behind various repair techniques, the rationale for annuloplasty ring selection, technical nuances of ring fixation, and surgical strategies for mitral annular disjunction (MAD). By integrating institutional experience with the latest evidence, participants will explore current best practices and future directions in mitral valve repair surgery.
|
Workshop |
| 5 |
To Cut or To Clip? The Quest for the Perfect LAA Closure
This session will focus on two contrasting approaches: the conventional cut-and-sew technique, which offers proven durability at the expense of greater invasiveness, and clip-based device therapy, which provides procedural simplicity but raises questions regarding cost and long-term effectiveness. By comparing these strategies, we will examine their respective strengths, limitations, and appropriate clinical indications, and discuss their roles in contemporary cardiovascular treatment.
|
Workshop |
| 6 |
Avoiding Pitfalls in Tricuspid Valve Surgery: Practical Tips for Optimal Outcomes
This session will focus on key pitfalls in tricuspid valve surgery, addressing technical and clinical challenges that can affect surgical outcomes. By sharing practical insights, operative refinements, and the latest evidence, participants will discuss strategies to overcome these challenges and optimize patient outcomes.
|
Workshop |
■Heart Failure
| Session Theme | ||
|---|---|---|
| 1 |
Current Status of VAD Therapy in Pediatric, Small-Bodied, and Congenital Heart Disease Patients
There remains no standardized approach to the use of implantable versus paracorporeal VADs in pediatric, small-bodied, and congenital heart disease patients, nor to the surgical adaptations required for these complex cases. As implantable VAD therapy is expected to expand in Japan, this session will provide an opportunity to share institutional experiences, technical refinements, and clinical outcomes, including acute mechanical circulatory support strategies, and to discuss optimal pathways for safely bridging patients to heart transplantation.
|
Panel Discussion |
| 2 |
Mechanical Circulatory Support for High-Risk Surgical Patients: By Failing to Prepare, You Are Preparing to Fail
This session will focus on cardiogenic shock associated with cardiac surgical disease, including preoperative shock caused by AMI, acute MR, ventricular septal rupture, and left ventricular rupture, as well as postoperative shock following surgery for ICM-MR, acute aortic dissection, and other complex conditions. By sharing institutional experiences, illustrative cases, and outcome data, we aim to discuss current challenges and optimal strategies for mechanical circulatory support and surgical management in these critically ill patients.
|
Workshop |
| 3 |
Challenges of Left Ventricular Assist Device (LVAD) Destination Therapy in Elderly Patients
Destination therapy (DT) with implantable left ventricular assist devices (LVADs) in elderly patients presents a wide range of challenges, including patient selection, management of device-related complications, quality of life, allocation of healthcare resources, and ethical considerations. In this session, we will examine the indications and limitations of DT for elderly patients from multiple perspectives, and discuss optimal future treatment strategies as well as the healthcare systems needed to support this growing patient population.
|
Workshop |
| 4 |
Regenerative Medicine, Gene Therapy, and AI: Translational Science Redesigning Heart Failure Treatment
In this session, we will provide an overview of the latest advances in regenerative medicine, gene therapy, and artificial intelligence (AI), and explore their translation from basic research to clinical practice. We will further discuss how these emerging technologies may reshape the concepts, indications, and timing of surgical intervention for heart failure, and consider their potential to transform the future of heart failure surgery.
|
Workshop |
■Coronary
| Session Theme | ||
|---|---|---|
| 1 |
Mastering Coronary Artery Bypass Grafting Within the First 15 Years After Graduation: Institutional Approaches and Training Strategies.
With the increasing adoption of PCI and MICS-CABG, opportunities for young surgeons to gain operative experience in conventional CABG have become limited. From the educators’ perspective, we aim to discuss the systematic development of training goals, teaching methods, case allocation, assessment strategies, and management of complications. From the trainees’ perspective, we will present the learning curve, practical tips for skill acquisition, and support needs. We will also share our institution’s educational framework, including procedural standardization and simulation-based training, along with its outcomes and remaining challenges. Finally, we will discuss a training roadmap designed to enable surgeons to achieve mastery of CABG by approximately 15 years after graduation.
|
Symposium |
| 2 |
The CABG I'm Passionate About
The objective of this session is to contribute to the future of CABG by sharing the unique commitment and passion for CABG demonstrated by speakers ranging from young surgeons to seasoned experts, and by fostering discussion and exchange of their perspectives and experiences.
|
Symposium |
| 3 |
Frontline Surgical Management for Postinfarction Mechanical Complication
Surgical experience with acute myocardial infarction complications—including VSP, papillary muscle rupture, and left ventricular rupture—is inherently limited. By sharing institutional experiences and broadening our knowledge of surgical strategies and treatment options, this session aims to enhance our ability to successfully manage these highly challenging cases.
|
Workshop |
| 4 |
The Indications and Limitations of CABG for Small-Caliber Coronary Arteries
In this session, we will revisit the role of coronary artery bypass grafting (CABG) for small-caliber coronary arteries, focusing on anatomical factors, physiological considerations, and surgical techniques, and discuss its indications as well as its limitations.
|
Workshop |
| 5 |
Precision CABG: Strategic Integration of Advanced Imaging
We would also like to discuss how the latest imaging modalities—including FFR-CT, intraoperative indocyanine green (ICG) fluorescence angiography, multislice computed tomography (CT), and cardiac magnetic resonance imaging (MRI) at the preoperative, intraoperative, and postoperative phases—should be integrated into surgical decision-making and strategy to explore the future direction of CABG.
|
Workshop |
■Thoracic Aorta
| Session Theme | ||
|---|---|---|
| 1 |
Preemptive TEVAR Really Reduced Open Surgery for Dissecting Aneurysm of Thoracoabdominal Aorta?
Impact of Preemptive TEVAR on Long-Term Outcomes in Type B Aortic Dissection: Has It Reduced the Need for Open Thoracoabdominal Aortic Surgery?
|
Symposium |
| 2 |
Training Aortic Surgeons for a New Era: Diverse Career Pathways and Effective Mentorship
Advanced open aortic surgery has been built on the lifelong experience of master surgeons. As generational transition progresses, technical inheritance has become a nationwide challenge in Japan. With the spread of endovascular therapy, opportunities to perform complex open repair also vary widely among institutions. This session will share educational practices across diverse centers and discuss mentorship, operative opportunities, and career pathways from both mentor and trainee perspectives.
|
Symposium |
| 3 |
Current Strategies and Perspectives for Chronic Dissecting Thoracoabdominal Aortic Aneurysms: Roles and Long-term Outcomes of Open, Endovascular, and Hybrid Approaches
Chronic dissecting thoracoabdominal aortic aneurysm represents a major challenge in the field of vascular surgery. This panel will bring together institutional experiences and long-term results of three treatment strategies: open surgery, which provides durable and dependable branch-vessel reconstruction; endovascular treatment employing advanced branched stent-graft technologies; and hybrid procedures that integrate the strengths of both approaches.
|
Panel Discussion |
| 4 |
Toward Zero Spinal Cord Ischemia: Controversies and Future Directions in Thoracoabdominal Aortic Aneurysm Repair
Spinal cord ischemia (SCI) remains a major complication after open repair of thoracoabdominal aortic aneurysm. Although operative mortality has improved, reductions in SCI have not necessarily kept pace. Guidelines support CSFD and blood pressure management, whereas the need for intercostal/segmental reimplantation and the indication or omission of CSFD remain controversial. This English-language panel will review current evidence and institutional practice, and discuss future directions toward zero SCI.
|
Panel Discussion |
| 5 |
Tips and Technical Strategies for Proximal Anastomosis at Zone 3 in Left Thoracotomy Aortic Surgery
Although the widespread use of TEVAR has reduced opportunities for younger surgeons to perform left thoracotomy aortic surgery, these procedures continue to require advanced technical skills and sound clinical judgment. This session will provide a platform for participating centers to share their treatment strategies, technical innovations, and clinical outcomes, with the goal of further improving the results of left thoracotomy aortic surgery.
|
Video Workshop |
| 6 |
Impact and Prevention of DANE/PANE After Surgery for Type A Aortic Dissection
This session aims to clarify the impact of DANE and PANE (excluding pseudoaneurysms) on both early and long-term outcomes, and to foster discussion on strategies for their prevention.
|
Workshop |
| 7 |
Technical Strategies for Coronary Reconstruction in Aortic Root Replacement with Complex Coronary Anatomy
This session will focus on reconstruction strategies for complex coronary artery anatomy in aortic root replacement, with discussion based on operative videos and the experiences of participating institutions.
|
Workshop |
■Abdominal Aorta and Peripheral Vessels
| Session Theme | ||
|---|---|---|
| 1 |
Risk Assessment and Prophylactic Strategies for Type II Endoleaks After EVAR: A Step Toward Standardization
Because Type II endoleaks after EVAR are multifactorial and difficult to predict, we seek presentations that, based on long-term outcomes, can help establish criteria for intervention and contribute to future guideline development.
|
Panel Discussion |
| 2 |
Critical Issues in Revascularization to CLTI
This session will discuss key clinical challenges for CLTI patients, including hybrid procedures, conversion to bypass surgery after unsuccessful EVT, and the optimal use of new devices such as DCBs.
|
Panel Discussion |
| 3 |
Tips for Peripheral Vascular Surgery Beneficial to Cardiac Surgeons
There are very few board-certified vascular surgeons, and in many institutions, peripheral vascular interventions are primarily performed by cardiac surgeons. The aim of this session is to showcase peripheral vascular surgical techniques performed by expert vascular surgeons through video presentations and to share their practical tips and technical pearls with cardiac surgeons.
|
Video Session |
| 4 |
Current Practice and Future Perspectives of CLTI Management in Regional Areas
CLTI care in rural and regional areas faces many challenges compared with urban settings. This session invites presentations based on real-world clinical practice, covering topics such as revascularization and wound management, multidisciplinary collaboration and care coordination, and strategies to improve treatment outcomes to share the unique innovations, practical solutions, and challenges encountered in regional CLTI management.
|
Workshop |
| 5 |
Onco-Vascular Surgery : Advanced Vascular Surgical Techniques for Solid Tumors
The role of cardiovascular surgeons in oncologic care is expanding. This session will focus on technical strategies and complication management for tumors involving major vascular structures, including the inferior vena cava (IVC), aorta, and abdominal visceral vessels. Through discussion of these challenging cases, we aim to explore approaches that enhance both the safety and curative potential of complex surgical procedures.
|
Workshop |
| 6 |
Management of Visceral Artery Aneurysm
This session will focus on practical treatment strategies for visceral artery aneurysms, including renal artery aneurysms. Topics for discussion include the indications for open surgical and endovascular treatment, device selection, hybrid approaches, management of complications, and long-term outcomes, with the goal of optimizing patient care and treatment results.
|
Workshop |
| 7 |
The Scinence of Aortic Diseases
Although atherosclerosis, genetic abnormalities, inflammation, and hemodynamic changes are recognized as major contributors to the development of aortic aneurysms and dissections, many aspects of their pathogenesis remain unclear. This session will discuss evidence derived from basic and translational research aimed at elucidating these underlying mechanisms and advancing our understanding of aortic disease.
|
Workshop |
■Congenital
| Session Theme | ||
|---|---|---|
| 1 |
What is the Best Surgical Strategy for Hypoplastic Left Heart Syndrome?: Feedback from Long-Term Outcome.
We retrospectively reviewed the long-term postoperative issues associated with hypoplastic left heart syndrome (HLHS) and, based on the insights gained, discussed optimal surgical strategies for the management of HLHS from the neonatal period onward.
|
Symposium |
| 2 |
Optimizing Right Ventricular Decompression Strategy for Pulmonary Atresia with Intact Ventricular Septum
The goal of this session is to discuss institutional experiences and identify the optimal management strategy for borderline right ventricular hypoplasia, focusing on initial right ventricular decompression, right ventricular growth-promoting interventions, and biventricular (including one-and-a-half ventricular) repair.
|
Panel Discussion |
| 3 |
Surgical Technique for Ebstein Disease -from Neonates to Adults-
In this session, we aim to deepen our understanding of Ebstein’s anomaly through video presentations of cases that required innovative surgical strategies.
|
Video Session |
President's Requested Session
■Valve and Arrhythmia
| Session Theme | |
|---|---|
| 1 |
Strategy for Initial SAVR with Future TAV-in-SAV in Mind
|
| 2 |
What Is the Optimal Mitral Valve Repair Strategy for Degenerative Posterior Leaflet Prolapse? Resection, Respect (Loop Technique), or Respect with Limited Resection
|
■Heart Failure
| Session Theme | |
|---|---|
| 1 |
Heart Failure Management in Patients with Adult Congenital Heart Disease: MCS, VAD, and Heart Transplantation
|
| 2 |
Percutaneous Ventricular Assist Devices: Reassessing their Use in Acute Heart Failure and Shock
|
| 3 |
Challenges in Heart Transplantation: Optimizing the Use of Marginal Donors
|
■Coronary
| Session Theme | |
|---|---|
| 1 |
Composite Vein Grafts in CABG: How Effective Are They?
|
■Thoracic Aorta
| Session Theme | |
|---|---|
| 1 |
Acute Type A Aortic Dissection: Treatment Strategies for Cerebral Malperfusion
|
| 2 |
Early and Long-Term Outcomes of Fenestrated/Branched Frozen Elephant Trunk Repair for Acute Aortic Dissection
|
| 3 |
Genome-Oriented Aortic Surgery: Preventive Extended Repair Strategies for Patients with Pathogenic Aortic Gene Variants
|
| 4 |
Pitfalls and Long-Term Outcomes of Valve-Sparing Surgery for Bicuspid Aortic Valve
|
| 5 |
Branched Stent-Grafts: An Overview of OTS, TBE, TAMBE, CTM, and PMEG
|
| 6 |
Branch Reconstruction Stents in Thoracoabdominal Aortic Endovascular Repair: Self-Expandable or Balloon-Expandable?
|
| 7 |
Establishing a Regional Aortic Dissection Network Utilizing Information and Communication Technology (ICT)
|
| 8 |
What Are the Outcomes of Endovascular Treatment for 3B Retrograde Aortic Dissection?
|
■Abdominal Aorta and Peripheral Vessels
| Session Theme | |
|---|---|
| 1 |
Mid- and Long-Term Outcomes of EVAR in Patients with Hostile Neck Anatomy
|
| 2 |
Long-Term Outcomes of Peroneal Artery Bypass Surgery
|
| 3 |
Late Open Surgical Conversion After EVAR
|
| 4 |
Indications and Outcomes of Revascularization for Intermittent Claudication
|
| 5 |
Indications for and Controversies Surrounding Prophylactic Branch Embolization in EVAR
|
| 6 |
Hybrid Revascularization for Infralinguinal Peripheral Arterial Disease
|
■Congenital
| Session Theme | |
|---|---|
| 1 |
How do We Manage for Multile VSD
|
| 2 |
Unifocalization in Fontan Strategy
|
| 3 |
Surgical Strategies for Borderline Left Ventricle
|
General Session (Oral/Poster/Video)
| A. Heart | |||
|---|---|---|---|
| A-01 | Congenital | A-01-01 | Congenital Heart Disease |
| A-01-02 | Adult Congenital | ||
| A-01-03 | Other | ||
| A-02 | Ischemic | A-02-01 | Coronary Artery Bypass |
| A-02-02 | Myocardial Infarction Complications | ||
| A-02-03 | Ischemic Cardiomyopathy | ||
| A-02-04 | Other | ||
| A-03 | Valvular Disease | A-03-01 | Aortic Valve |
| A-03-02 | TAVI | ||
| A-03-03 | Mitral Valve | ||
| A-03-04 | Mitral Valve (Functional MR) | ||
| A-03-05 | Tricuspid Valve | ||
| A-03-06 | Combined Valvular Disease | ||
| A-03-07 | MICS | ||
| A-03-08 | Other | ||
| A-04 | Endocarditis | ||
| A-05 | Arrhythmia | ||
| A-06 | Heart Failure・VAD・Heart Transplantation | ||
| A-07 | Other Heart Diseases | ||
| A-08 | Extracorporeal Circulation・Assist Circulation | ||
| A-09 | Intraoperative and Postoperative Management | ||
| A-10 | Postoperative Complications | ||
| A-11 | Examination・Diagnosis | ||
| A-12 | Basic Research | ||
| A-13 | Other | ||
| B. Vessels | |||
|---|---|---|---|
| B-01 | Aortic Dissection | B-01-01 | Type A Dissection |
| B-01-02 | Type B Dissection | ||
| B-01-03 | Chronic Dissection | ||
| B-01-04 | Dissection Complications | ||
| B-01-05 | Other | ||
| B-02 | Thoracic Aorta | B-02-01 | Aortic Root |
| B-02-02 | Ascending Arch | ||
| B-02-03 | Descending | ||
| B-02-04 | Extensive Aneurysm | ||
| B-02-05 | Other | ||
| B-03 | Thoracoabdominal Aorta | ||
| B-04 | Abdominal Aorta | ||
| B-05 | Peripheral Artery | ||
| B-06 | Vein | ||
| B-07 | Pulmonary Artery | ||
| B-08 | Stent Graft | B-08-01 | Thoracic |
| B-08-02 | Thoracoabdominal | ||
| B-08-03 | Abdominal | ||
| B-08-04 | Aortic Dissection | ||
| B-08-05 | Peripheral Artery | ||
| B-08-06 | Other | ||
| B-09 | Perioperative Management | ||
| B-10 | Examination・Diagnosis | ||
| B-11 | Basic Research | ||
| B-12 | Other | ||
| C. Regenerative Medicine | |||
|---|---|---|---|
| C-01 | Regenerative Medicine | C-01-01 | Regenerative Medicine |
| C-01-02 | Latest Technology | ||
| C-01-03 | Other | ||
| D. Team Medical Care | |||
|---|---|---|---|
| D-01 | Team Medical Care | D-01-01 | Education・Training |
| D-01-02 | Team Medical Care | ||
| D-01-03 | Other | ||
| E. Other | |
|---|---|
| E-01 | Other |
[Application for the Best Abstract Award]
- Please indicate your wish to apply during the abstract submission process.
- Submit your abstract as a General Abstract. Select the appropriate scientific category/field when submitting.
- The recipient of the Best Abstract Award will be invited to present at the AHA (American Heart Association Scientific Sessions).
[Application for the EACTS Recommended Abstract Award]
- Please indicate your wish to apply during the abstract submission process.
- Submit your abstract as a General Abstract.
- Select the appropriate scientific category/field when submitting.
- Authors of abstracts selected for the EACTS Recommended Abstract Award will be required to submit an English abstract to EACTS and subsequently submit a manuscript to EJCTS.
- As presentations will be conducted in English, the selection process will include an online interview to assess English proficiency.
- Only abstracts that have not been previously presented or submitted to any other scientific meeting or journal are eligible.
Please strictly adhere to this requirement. - Abstracts in the field of Peripheral Vessels are not eligible for this award.
[Other Notes]
- Due to program scheduling requirements, we may request a different presentation format than what you registered. Please understand this in advance.
- If main theme sessions are not accepted, please also select whether you wish to present as a video presentation or general presentation.
- When applying for either type of presentation, acceptance will be determined again in the same manner as general presentations.
- After selecting a general abstract, please choose whether or not you would like to accept a presentation in the thematic session. If your abstract is judged to be excellent as a result of peer review, you may be asked to present it in the thematic session.
- Please note that the presentation categories for general presentations and video presentations may be changed from your registered category depending on content and available presentation slots.
Character Limit
- English presentation title：No limit
- Maximum number of registrable authors (lead author + co-authors)： Up to 21
- Maximum number of registrable affiliated institutions：Up to 10
Presentation Language
| Main Theme Session | General Presentations | |
|---|---|---|
| Abstract Language | Japanese or English | Japanese or English (either acceptable) |
| Slide Language | ||
| Presentation Language |
Application Method
For applications to this conference, please submit slide-format abstract PDFs rather than text-based abstracts.
Important Notes for Slide Creation
- Please create slide-format abstracts using the template and compile them into exactly 7 slides. You may use photographs, figures, and tables.
- Please convert to PDF and upload to the presentation registration system. Do not embed videos.
- Please do not include your affiliation or name in the slide-format abstract, as this information will be entered into the presentation registration system.
- You may use different text colors and styles (bold, etc.) for better readability, but please ensure the main text font size is at least 28 points (excluding text within figures and tables).
- Figures and tables may be inserted. The number of figures and tables is not restricted to the template layout frames.
- Please create slides in 16:9 format.
- The maximum file size for uploaded PDF data is 10MB. Please ensure your file is within this limit.
-
Please structure the 7 slides with the following content:
・Slide 1: Title
・Slide 2: Background and Objective
・Slide 3: Subjects
・Slide 4: Methods
・Slide 5: Results 1
・Slide 6: Results 2
・Slide 7: Conclusion -
If you are using macOS, an upload error may occur if your filename contains the following half-width characters. In such cases, please remove these characters from the filename.
¥ ⁄ : * ? " > < |
Please download the template from the button below.
PDF Conversion Method
- For PowerPoint：
File > Export > Create PDF/XPS: Select the "Minimum size (online publishing) (M)" radio button > Publish
- For Keynote：
File > Export > Select PDF > Next > Enter filename and select destination folder > Export
Presentation Registration Method
Registration is only available online through the presentation registration system. Please register using the "New Presentation Registration" button at the bottom of this page.
Presentation Registration and Password
A registration number and password will be issued upon presentation registration. During the presentation registration period, you can check, modify, and delete your presentation using the registration number and password, so please manage them carefully and do not forget them. To maintain security, we cannot respond to any inquiries regarding passwords.
Presentation Receipt and Acceptance Notification
1. Presentation Receipt Confirmation
When you register, modify, or delete a presentation, an automatic email will be sent to the email address you entered during application. Please be sure to check this automatic email. This email serves as your receipt notification. If you do not receive the receipt notification email within one day after registration, it may have been filtered into your spam folder or registration may not have been completed. If it is not in your spam folder, please check from the "Confirmation/Modification Screen" to ensure your registered email address is correct. If your email address is correct, please contact the management office before the presentation application deadline.
Management Office E-mail: jscvs2027-abs@m.congre.co.jpd
2. Presentation Acceptance and Presentation Schedule
Notification of presentation acceptance will be sent to the email address entered during presentation registration in early December.
Presentation Registration
Inquiries Regarding Presentation Registration Methods
57th Annual Scientific Meeting of the Japanese Association for Thoracic
Surgery Management Office Congre Inc.
TEL：03-3510-3701 FAX：03-3510-3702
E-mail：jscvs2027-abs@m.congre.co.jpd
